We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ceva Takes Commercial License for ProBioGen’s AGE1.CR Cell Line

Product News   Mar 20, 2012

 
Ceva Takes Commercial License for ProBioGen’s AGE1.CR Cell Line
FURTHER INFORMATION
 
 
 

Related Product News

Infectious Diseases Clinical Research Consortium Grants Announced

Product News

The National Institute of Allergy and Infectious Diseases (NIAID) has announced the establishment of the Infectious Diseases Clinical Research Consortium, a clinical trials network that will encompass the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs) and create a new consortium leadership group.

READ MORE

Funding Awarded For Yellow Fever Vaccine Development

Product News

Newcells Biotech has announced that they have been awarded further funding to continue development of their model of the human liver, designed for the routine assessment of Yellow Fever vaccine attenuation.

READ MORE

Prokarium Announces MHRA Acceptance To Run Phase I Trial of Enteric Fever Vaccine

Product News

Prokarium has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with a bivalent vaccine against enteric fever.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE